RhumbLine Advisers

RhumbLine Advisers’s Elevation Oncology ELEV Stock Holding History

RhumbLine Advisers’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$20.4K	Buy
2024 Q4	$39.4K	Buy
2024 Q3	$38.8K	Sell
2024 Q2	$175K	Buy